| Literature DB >> 32685506 |
Bing Hu1, Yun Li2, Guilian Wang1, Yanqing Zhang1.
Abstract
Kawasaki disease (KD) is an acute vasculitis, accompanied by coronary artery aneurysm, coronary artery dilatation, arrhythmia, and other serious cardiovascular diseases. So far, the etiology of KD is unclear; it is necessary to study the molecular mechanism and related factors of KD. In this study, we analyzed the expression profiles of 75 DB (identifying bacteria), 122 DV (identifying virus), 71 HC (healthy control), and 311 KD (Kawasaki disease) samples. 332 key genes related to KD and pathogen infections were identified using a combination of advanced feature selection methods: (1) Boruta, (2) Monte-Carlo Feature Selection (MCFS), and (3) Incremental Feature Selection (IFS). The number of signature genes was narrowed down step by step. Subsequently, their functions were revealed by KEGG and GO enrichment analyses. Our results provided clues of potential molecular mechanisms of KD and were helpful for KD detection and treatment.Entities:
Mesh:
Year: 2020 PMID: 32685506 PMCID: PMC7327570 DOI: 10.1155/2020/6062436
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1The IFS curve of Kawasaki disease signature gene selection. The x axis was the number of top genes and the y axis was the LOOCV accuracy. The highest LOOCV accuracy was 0.933 when 332 genes were used. Therefore, these 332 genes were selected as Kawasaki disease signature genes.
The confusion matrix of the 332 genes.
| ActualDB | ActualDV | ActualHC | ActualKD | |
|---|---|---|---|---|
| PredictedDB | 57 | 4 | 1 | 2 |
| PredictedDV | 13 | 116 | 5 | 6 |
| PredictedHC | 2 | 0 | 65 | 1 |
| PredictedKD | 3 | 2 | 0 | 302 |
| Sample size | 75 | 122 | 71 | 311 |
| Accuracy | 0.760 | 0.951 | 0.915 | 0.971 |
KEGG and GO enrichment results of the 332 genes.
| Category | Function | FDR |
|---|---|---|
| KEGG | hsa05164 influenza A | 0.012638 |
| hsa05169 Epstein-Barr virus infection | 0.012638 | |
| hsa05160 hepatitis C | 0.012834 | |
| hsa05322 systemic lupus erythematosus | 0.012834 | |
| hsa05162 measles | 0.013912 | |
|
| ||
| GO BP∗ | GO:0006955 immune response | 7.29 |
| GO:0002252 immune effector process | 2.36 | |
| GO:0006952 defense response | 1.09 | |
| GO:0002376 immune system process | 1.82 | |
| GO:0045087 innate immune response | 3.95 | |
| GO:0019221 cytokine-mediated signaling pathway | 9.28 | |
| GO:0051707 response to other organisms | 7.40 | |
| GO:0043207 response to external biotic stimulus | 7.40 | |
| GO:0009607 response to biotic stimulus | 3.25 | |
| GO:0060337 type I interferon signaling pathway | 6.82 | |
|
| ||
| GO MF | GO:0001730 2′-5′-oligoadenylate synthetase activity | 0.008883 |
| GO:0003725 double-stranded RNA binding | 0.008883 | |
| GO:0050786 RAGE receptor binding | 0.02261 | |
|
| ||
| GO CC∗ | GO:0044433 cytoplasmic vesicle part | 1.54 |
| GO:0031982 vesicle | 1.31 | |
| GO:0005737 cytoplasm | 1.59 | |
| GO:0044444 cytoplasmic part | 3.60 | |
| GO:0031410 cytoplasmic vesicle | 1.81 | |
| GO:0097708 intracellular vesicle | 1.81 | |
| GO:0042581 specific granule | 2.16 | |
| GO:0030141 secretory granule | 2.45 | |
| GO:0005829 cytosol | 4.43 | |
| GO:0012505 endomembrane system | 6.44 | |
∗Since there were too many enriched “GO BP” and “GO CC” terms, only the top 10 terms were listed.